Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26337188 | 0.87 | HSD17B10 (0.32) | — | |
| SCHEMBL18653659 | 0.81 | LMNA (0.43) | LMNAMGAM | |
| SCHEMBL17751193 | 0.81 | LMNA (0.43) | LMNAMGAM | |
| SCHEMBL25839232 | 0.81 | LMNA (0.43) | LMNAMGAM | |
| SCHEMBL13179496 | 0.74 | LMNA (0.40) | LMNAMGAM | |
| SCHEMBL28776415 | 0.72 | — | — | |
| SCHEMBL13770691 | 0.72 | — | — | |
| SCHEMBL23220483 | 0.71 | TDP1 (0.36) | — | |
| SCHEMBL21782825 | 0.71 | TDP1 (0.36) | — | |
| SCHEMBL23220490 | 0.71 | TDP1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230248757-A1 | Altering Net Charge on Mannosylated Dextrans to Maximize Target Tissue Uptake and Off Target Competitive Blocking | SCOTT, JOHN KIM, JR. | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230248757-A1 | Altering Net Charge on Mannosylated Dextrans to Maximize Target Tissue Uptake and Off Target Competitive Blocking | CD209, FUT6, SIGLEC7 | LMNA 2628/4885MGAM 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.